|
CIBMTR is a research collaboration between the NMDP/Be The Match and Medical College of Wisconsin.
|
|
TEST Yourself
We conducted a 'jeopardy-like' game for the attendees at our CRP/DM 2015 Conference, to which most of the questions were answered right. A post-game report also revealed five questions that less than 70% of the participants answered correctly. Perhaps you'd like to test yourself on those stumpers?
Category: Pre-TED 2400 Form
Report that a recipient is participating in a clinical trial only if CIBMTR is providing outcomes data.
a. True
b. False
To update the transplant date on a Pre-TED form 2400 for a subsequent transplant:
a. Edit the CRID 2804
b. Edit the last follow-up form of the previous transplant
c. Edit the subsequent transplant's Pre-TED
d. Send a 2800 with the updated subsequent transplant date
Category: Baseline Form 2000
The Baseline (form 2000) collects the dosing body weight used for the preparative regimen. The dosing body weight is:
a. the actual weight of the patient
b. the ideal body weight
c. an adjusted body weight
d. the actual or adjusted body weight
Under 'Clinical Status of recipient prior to the Preparative Regimen' section, the question about smoking is referring to:
a. use of cigars, pipe tobacco, cigarettes, and chewing tobacco
b. smoking anytime in the recipient's lifetime
c. cigarette smoking only
d. marijuana
Category: CRID 2804
After a form is submitted to CIBMTR, a Data Manager can correct a birth date error electronically on a Pre-TED 2400?
a. True
b. False
|
|
What's New Recap:
Training Materials
A web page change: "Data Matters Training Newsletter Issues" has been renamed as the archive page for: Newsletters and eBlasts
Forms Instruction Manual
Our main data management resource containing explanatory text for each CIBMTR form question now has more powerful search options to quickly find what you are searching for. This new tool renders well for both desktop and mobile browsers. Individual form instruction updates are displayed directly below each form's instructions with a section that invites your feedback.
FormsNet - New Forms Release
Indication for CRID Assignment (Form 2814) collects information to initiate CIBMTR reporting on appropriate research or data collection forms. This form must be completed for the first indication requiring the individual to register for a CIBMTR Research ID (CRID). Manual and eLearning
Revised CIBMTR Research ID Assignment Form 2804 - Manual and eLearning
Compliance
Pre-TED Form (Form 2400) is now required for all autologous transplant recipients, whether or not they consent to have their data used in research.
|
Question: NHL Transformation/Relapse Reporting
Situation - A patient that was diagnosed with CLL in 2001. By 2011, a Richter's transformation occurred and the patient had an autologous HCT for DLBCL. The patient was in CR at the time of transplant. The version of the Pre-TED (Form 2400) that was completed and submitted did not ask about transformation, so the patient was reported as having Non-Hodgkin's Lymphoma (DLBCL) with CLL as a comorbidity. Now, the patient has a recurrence of CLL. Should this be reported as a relapse?
Answer:
Yes, this should be reported as a relapse of the NHL, regardless of the Pre-TED version. It's along the same line as when MDS transforms to AML. Once patients have transformed to AML, any disease relapse (whether it's MDS or AML) will be reported as an AML relapse.
Question: Multiple Myeloma on the Form 2450
Question #79 states, "Was a CR ever achieved in response to HCT?" Many of our patients do not undergo a bone marrow biopsy following their transplant if they appear to be in CR. However, by the CR criteria listed in the forms instruction manual, we must ensure that there are less than 5% plasma cells in the bone marrow. For these patients who don't have bone marrow biopsies but appear to be in CR from the negative immunofixation and absence of plasmacytomas, is it correct to mark "not evaluated" or "no, never in CR from HCT"?
Answer:
Since most patients undergo some evaluation (even if not a complete evaluation), it's not appropriate to report "not evaluated". Not evaluated should only be used when there hasn't been any evaluation performed. If there's never been a bone marrow biopsy before or after HCT that documents <5% plasma cells, the center should report "no, never in CR from HCT".
|
